Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation

Meta-analysis: Combination Endoscopic and Drug Therapy to Prevent Variceal Rebleeding in Cirrhosis

(2013) Rosario Gonzalez et al.   ANNALS OF INTERNAL MEDICINE

Development of Ascites in Compensated Cirrhosis With Severe Portal Hypertension Treated With β-Blockers

(2012) Virginia Hernández-Gea et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

(2012) Thomas Reiberger et al.   GUT

The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease: Figure 1

(2012) Aleksander Krag et al.   GUT

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

(2012) Thomas Reiberger et al.   JOURNAL OF HEPATOLOGY

Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study

(2011) Thomas Sersté et al.   JOURNAL OF HEPATOLOGY

Elective Liver Transplant List Mortality: Development of a United Kingdom End-Stage Liver Disease Score

(2011) Kerri Barber et al.   TRANSPLANTATION

Beta-blockers in cirrhosis: Friend and foe?

(2010) Florence Wong et al.   HEPATOLOGY

Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites?

(2010) Thierry Thevenot et al.   HEPATOLOGY

Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?

(2010) Aleksander Krag et al.   HEPATOLOGY

Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites

(2010) Gin-Ho Lo   HEPATOLOGY

Beta-blockers in patients with cirrhosis and refractory ascites

(2010) Albillos Agustín et al.   HEPATOLOGY

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

(2010) Thomas Sersté et al.   HEPATOLOGY

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

(2010)   JOURNAL OF HEPATOLOGY

Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension

(2010) Roberto de Franchis   JOURNAL OF HEPATOLOGY

Management of Varices and Variceal Hemorrhage in Cirrhosis

(2010) Guadalupe Garcia-Tsao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies

(2010) Peter C. Austin   PHARMACEUTICAL STATISTICS

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites

(2009) A Krag et al.   GUT

β-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis

(2009) Marco Senzolo et al.   LIVER INTERNATIONAL

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

(2009) Peter C. Austin   STATISTICS IN MEDICINE